Masimo Corporation (BMV:MASI)
Mexico · Delayed Price · Currency is MXN | Market Cap | 162.35B +1.8% |
| Revenue (ttm) | 27.84B +9.2% |
| Net Income | 1.36B |
| EPS | 25.38 |
| Shares Out | n/a |
| PE Ratio | 119.12 |
| Forward PE | 28.92 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20 |
| Average Volume | 248 |
| Open | 3,113.22 |
| Previous Close | 2,562.13 |
| Day's Range | 3,070.00 - 3,113.22 |
| 52-Week Range | 2,562.13 - 3,113.22 |
| Beta | n/a |
| RSI | 49.74 |
| Earnings Date | Aug 4, 2026 |
About Masimo
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also pro... [Read more]
Financial Performance
In fiscal year 2025, Masimo's revenue was $1.53 billion, an increase of 9.44% compared to the previous year's $1.40 billion. Losses were -$151.50 million, -50.31% less than in 2024.
Financial numbers in USD Financial StatementsNews
Masimo Earnings release: Q1 2026
Masimo released its Q1 2026 earnings on May 26, 2026, summarizing the period's financial results.
Masimo shareholders approve acquisition by Danaher
Masimo (MASI) announced that its stockholders voted in favor of the proposal to adopt the previously announced Agreement and Plan of Merger, dated February 16, 2026, by and among Masimo,…
Masimo Shareholders Approve Acquisition by Danaher
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to...
Masimo Transcript: EGM 2026
Shareholders approved the merger with Danaher and an advisory compensation proposal. The CEO highlighted strategic achievements and the benefits of joining Danaher, with Masimo to remain an independent operating company within Danaher's diagnostics sector.
Masimo announces findings of study of accuracy of Masimo SET pulse oximetry
Masimo (MASI) announced the findings of a study evaluating the accuracy of Masimo SET pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical bias. Importantly,...
Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--A NICU study evaluating Masimo SET® pulse oximetry on hospitalized newborns found no clinically significant differences in accuracy across skin tones.
Masimo Proxy statement: Proxy filing
Masimo filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.
Masimo awarded $100M Defense Logistics Agency contract modification
Masimo (MASI) has been awarded a maximum $100M modification exercising the five-year option period of a five-year base contract with one five-year option period for patient monitoring and capital equi...
Masimo Proxy statement: Proxy filing
Masimo filed a proxy statement on April 1, 2026, providing details for shareholder voting and corporate governance matters.
Masimo downgraded to Market Perform from Outperform at Raymond James
Raymond James downgraded Masimo (MASI) to Market Perform from Outperform without a price target The firm expects the announced acquisition by Danaher (DHR) to close in Q2 or Q3 with…
Early ruling says Apple Watch redesign not infringing patents, Bloomberg reports
A redesigned Apple Watch doesn’t infringe two Masimo (MASI) patents, a U.S. trade judge found in an early win for Apple (AAPL) that could allow imports of the device if…
Judge approves Apple Watch redesign in Masimo patent case, Bloomberg says
11:17 EDT Judge approves Apple (AAPL) Watch redesign in Masimo (MASI) patent case, Bloomberg says
Masimo Proxy statement: Proxy Filing
Masimo filed a proxy statement on March 18, 2026, providing details for shareholder voting and corporate governance matters.
Masimo assumed with an Equal Weight at Wells Fargo
Wells Fargo assumed coverage of Masimo (MASI) with an Equal Weight rating and $180 price target The firm is maintaining the current rating, price target and estimates. Published first on…
Masimo Annual report: Q4 2025
Masimo has published its Q4 2025 annual report on February 27, 2026.
Halper Sadeh LLC is Investigating Whether KW and MASI are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
Halper Sadeh LLC is Investigating Whether MASI and KW are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
What's Happening With Masimo Stock?
Masimo stock (MASI) has faced a challenging year, trailing the broader market with a -3% annual return. While shares surged 34% yesterday following news of an acquisition by Danaher, this spike only p...
Masimo moved to No Rating at BofA
BofA moved from Neutral to No Rating on Masimo (MASI) after Danaher (DHR) agreed to acquire the company for a total consideration of $9.9B, or $180 per share. Published first…
Masimo downgraded to Neutral from Buy at BTIG
BTIG analyst Marie Thibault downgraded Masimo (MASI) to Neutral from Buy following the announcement that Danaher (DHR) entered a definitive agreement to acquire the company for $180/share in cash. BTI...
Masimo downgraded to Hold from Buy at Stifel
Stifel downgraded Masimo (MASI) to Hold from Buy with an $180 price target after the company agreed to be acquired by Danaher (DHR) for about $9.9B, or $180 per share.
Masimo downgraded to Neutral from Overweight at Piper Sandler
Piper Sandler analyst Jason Bednar downgraded Masimo (MASI) to Neutral from Overweight with a price target of $180, down from $210, after the company entered into an agreement pursuant to…
Morning Movers: Masimo surges, Danaher slumps after $9.9B deal
Stock futures are generally trading lower, reflecting renewed concerns about artificial intelligence-related disruption after last week’s weakness in tech and software stocks. Markets are broadly soft...